Channing Der Archives - UNC Lineberger Comprehensive Cancer Center

Headshots of Channing Der and Jen Jen Yeh

Channing J. Der, PhD, and Jen Jen Yeh, MD, published an editorial contextualizing a landmark clinical study evaluating daraxonrasib, a first-in-class drug targeting KRAS-mutant metastatic pancreatic ductal adenocarcinoma (PDAC).

AACR Annual Meeting, April 17-22, 2026 in San Diego.

UNC Lineberger researchers will present findings, chair sessions, lead session discussions and share their perspectives in topical forums and education sessions during the AACR Annual Meeting.

UNC Lineberger researchers and colleagues have discovered an important overlap in genes regulated by the activity of three proteins that support the growth of pancreatic cancer.

Headshots of Channing Der and Adrienne Cox.

NIH Director Monica Bertagnolli, MD, wrote about research led by UNC Lineberger’s Channing Der, PhD, and Adrienne Cox, PhD, that provided the most comprehensive molecular portrait of the workings of KRAS.

Channing Der presents at the 2024 UNC Lineberger Scientific Symposium.

UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.

UNC Lineberger researchers have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene, and how its activities impact pancreatic cancer outcomes.

UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.

The National Cancer Institute has awarded the UNC Lineberger Pancreatic Cancer Center of Excellence a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant.

Tag: Channing Der

Der, Yeh provide scientific context for recent progress in RAS therapeutics for pancreatic cancer

STAT: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades

UNC Lineberger and UNC faculty and trainees scheduled to present findings at American Association of Cancer Research Annual Meeting

New drug combinations found to potentially be more effective in targeting pancreatic cancers

NIH Director’s blog features pancreatic cancer research led by Der and Cox

Scientific symposium highlights latest developments in pancreatic cancer research

Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed

Inside Precision Medicine: Most Comprehensive Molecular KRAS Portrait to Date Can Inform Pancreatic Cancer Treatment Response

American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research

UNC Lineberger pancreatic cancer therapy studies backed by 5-year, $10.9 million NIH SPORE grant